vivax

vivax

Current status of Plasmodium vivax vaccine

Tags:

Author(s):

Myriam Arévalo-Herrera, Chetan Chitnis and Sócrates Herrera

Reference:

Human Vaccines, Volume 6, Issue 1, January 2010

The increasing P. vivax drug resistance and reports of severe and lethal cases, the relapsing parasite behavior and the existence of Plasmodium spp co-infections must prompt more investment and greater efforts for the development of P. vivax vaccine.

Medical Treatment:

vaccine

vivax

plasmodium

Vaccines against malaria: Perspectives from Papua New Guinea

Author(s):

Ivo Mueller, Blaise Genton, Inoni Betuela and Michael P. Alpers

Reference:

Human Vaccines, Volume 6, Issue 1, January 2010

Despite its small population and isolate location Papua New Guinea (PNG) with a malaria burden comparable to sub-Saharan Africa, its intense transmission of all 4 human Plasmodium species and an unrivalled combination of environmental and human variation offers unique perspectives on malaria vaccines.

Technology:

Continent:

Country:

Medical Condition:

Medical Treatment:

Search form

You are here